Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial

BMC Cancer
Peter ReichardtMichael C Heinrich

Abstract

Several small studies indicated that the genotype of KIT or platelet-derived growth factor receptor-α (PDGFRA) contributes in part to the level of clinical effectiveness of sunitinib in gastrointestinal stromal tumor (GIST) patients. This study aimed to correlate KIT and PDGFRA mutational status with clinical outcome metrics (progression-free survival [PFS], overall survival [OS], objective response rate [ORR]) in a larger international patient population. This is a non-interventional, retrospective analysis in patients with imatinib-resistant or intolerant GIST who were treated in a worldwide, open-label treatment-use study (Study 1036; NCT00094029) in which sunitinib was administered at a starting dose of 50 mg/day on a 4-week-on, 2-week-off schedule. Molecular status was obtained in local laboratories with tumor samples obtained either pre-imatinib, post-imatinib/pre-sunitinib, or post-sunitinib treatment, and all available data were used in the analyses regardless of collection time. The primary analysis compared PFS in patients with primary KIT exon 11 versus exon 9 mutations (using a 2-sided log-rank test) and secondary analyses compared OS (using the same test) and ORR (using a 2-sided Pearson χ(2) test) in the same mole...Continue Reading

References

May 10, 2002·The American Journal of Pathology·Christopher L CorlessMichael C Heinrich
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
Jan 11, 2003·Science·Michael C HeinrichJonathan A Fletcher
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichJonathan A Fletcher
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cristina R AntonescuPeter Besmer
Sep 3, 2004·Nature Reviews. Cancer·Nick J DibbClifford D Mol
Jun 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cristina R AntonescuRonald P DeMatteo
Sep 7, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichJonathan A Fletcher
Nov 28, 2007·Annual Review of Pathology·Christopher L Corless, Michael C Heinrich
Feb 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles D BlankeHeikki Joensuu
Jul 16, 2008·The Journal of Pathology·B LieglJ A Fletcher
Oct 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichGeorge D Demetri
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ketan S GajiwalaGeorge D Demetri
Mar 14, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S GeorgeG D Demetri
Apr 25, 2009·International Journal of Clinical Oncology·Toshirou NishidaUNKNOWN Japanese Study Group on GIST
Sep 10, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·George D DemetriRobert G Maki
Mar 1, 2012·World Journal of Gastroenterology : WJG·Jian LiLin Shen
Jun 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·George D DemetriPaolo G Casali
May 3, 2014·Therapeutic Advances in Medical Oncology·César Serrano, Suzanne George

❮ Previous
Next ❯

Citations

Mar 28, 2017·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Hui Shan OngChen Ping Zhang
Apr 18, 2018·The British Journal of Surgery·W T A van der GraafJ H W de Wilt
Apr 17, 2018·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Hui Shan OngWei Cao
Jun 6, 2019·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·Jingyi YanWei Chen
Oct 11, 2017·Expert Review of Anticancer Therapy·Hanna Koseła-Paterczyk, Piotr Rutkowski
Apr 19, 2018·Nature Reviews. Clinical Oncology·Armelle DufresneJean-Yves Blay
Jun 6, 2018·Frontiers in Oncology·Lin MeiSosipatros A Boikos
Dec 15, 2020·Expert Opinion on Pharmacotherapy·Antoine Italiano
Oct 3, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yemarshet K GebreyohannesPatrick Schöffski
Jan 30, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Robert Roskoski
Jul 16, 2021·Therapeutic Advances in Medical Oncology·Margherita NanniniMaria Abbondanza Pantaleo
Aug 12, 2021·Molecular Cancer Therapeutics·Sudeep BanerjeeJason K Sicklick
Sep 11, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sebastian BauerPatrick Schöffski

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies

Clinical Trials Mentioned

NCT01459757
NCT00094029

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.